Attached files
file | filename |
---|---|
10-K - Inspyr Therapeutics, Inc. | v178988_10k.htm |
EX-31.1 - Inspyr Therapeutics, Inc. | v178988_ex31-1.htm |
EX-31.2 - Inspyr Therapeutics, Inc. | v178988_ex31-2.htm |
EX-32.1 - Inspyr Therapeutics, Inc. | v178988_ex32-1.htm |
EX-4.27 - Inspyr Therapeutics, Inc. | v178988_ex4-27.htm |
EX-4.28 - Inspyr Therapeutics, Inc. | v178988_ex4-28.htm |
Exhibit
32.2
Certification
Pursuant to 18 U.S.C. Section 1350,
As
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In
connection with the GenSpera, Inc. (the “Company”) Annual Report on Form 10-K
for the year ended December 31, 2009 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Craig Dionne, Chief Financial
Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of
my knowledge:
(1). The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
(2). The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date: March 31, 2010
/s/ Craig Dionne
|
|
Craig
Dionne
|
|
Chief
Financial Officer
|
|
(Principal
Accounting Officer)
|